Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 4

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 4
---
angement, including as a result of limited conditionality and no required regulatory approvals, (viii)the“deal protection”provisions of the Agreement, (ix)the Company’s ability to respond to unsolicited superior proposals under the terms of the Agreement and the ability for the Board to change its recommendation in certain circumstances, (x)the support of the Company’s directors and officers,(xi)the Company’s ability to endeavour to monetize its programs and intellectual property in the interim period,(xii)the required shareholder and court approvals required to complete the Arrangement, (xiii)the treatment of the holders of Incentive Securities, (xiv)the ability of the

2

Company’s shareholders to dissent in respect of the Arrangement, (xv)the equal treatment of Shareholders under the terms of the Agreement, (xvi)advice from management and its legal and financial advisors, and (xvii)the opinion of Leerink Partners dated November14, 2025, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the cash consideration to be received by the Shareholders (other than holders of Excluded Shares) pursuant to the Arrangement is fair, from a financial point of view, to the Shareholders and that the Arrangement is in the best interests of the Company. The Transaction Committee unanimously recommended to the Board that it approve the Agreement and recommend that the Shareholders vote in favour of the Arrangement Resolution.

After taking into consideration, among other things, the factors enumerated in the preceding paragraph and the unanimous recommendation of the Transaction Committee, the Board has concluded that the Arrangement is advisable and is in the best interests of the Company and has approved the Arrangement and authorized its submission to the Shareholders. Accordingly, the Board unanimously recommends that Shareholders vote FOR the Arrangement Resolution. It is a condition to the completion of the Arrangement that the Arrangement Resolution be approved by Shareholders at the Special Meeting.

We are seeking approval of the Arrangement Resolution by the
affirmative vote of not less than (i) 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and
(ii) a simple majority of the votes attached to Common Shares held by Shareholders present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common